Amprius Technologies (NYSE:AMPX) Trading Up 1% on Analyst Upgrade

Amprius Technologies, Inc. (NYSE:AMPX)’s share price shot up 1% on Tuesday after B. Riley Financial raised their price target on the stock from $16.00 to $22.00. B. Riley Financial currently has a buy rating on the stock. Amprius Technologies traded as high as $18.95 and last traded at $17.9060. 14,053,794 shares changed hands during trading, an increase of 53% from the average session volume of 9,190,763 shares. The stock had previously closed at $17.72.

Other research analysts have also recently issued research reports about the stock. Roth Mkm restated a “buy” rating and set a $20.00 target price (up from $16.00) on shares of Amprius Technologies in a research note on Friday. Cantor Fitzgerald upped their price target on Amprius Technologies from $16.00 to $20.00 and gave the stock an “overweight” rating in a research note on Friday. Craig Hallum increased their price objective on shares of Amprius Technologies from $17.00 to $21.00 and gave the company a “buy” rating in a report on Friday. Needham & Company LLC initiated coverage on shares of Amprius Technologies in a report on Thursday, January 29th. They issued a “buy” rating and a $20.00 target price on the stock. Finally, Oppenheimer restated an “outperform” rating and set a $17.00 target price on shares of Amprius Technologies in a research report on Tuesday, December 23rd. Eight investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $19.75.

Insider Activity at Amprius Technologies

In other Amprius Technologies news, CTO Constantin Ionel Stefan sold 492,827 shares of Amprius Technologies stock in a transaction that occurred on Thursday, January 22nd. The stock was sold at an average price of $12.04, for a total value of $5,933,637.08. Following the sale, the chief technology officer owned 748,696 shares of the company’s stock, valued at $9,014,299.84. The trade was a 39.70% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Kang Sun sold 950,548 shares of the company’s stock in a transaction that occurred on Friday, January 16th. The stock was sold at an average price of $11.07, for a total value of $10,522,566.36. Following the sale, the director directly owned 1,403,651 shares in the company, valued at $15,538,416.57. This trade represents a 40.38% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 2,392,269 shares of company stock valued at $26,384,359 in the last 90 days. 12.80% of the stock is currently owned by company insiders.

Amprius Technologies News Summary

Here are the key news stories impacting Amprius Technologies this week:

• Positive Sentiment: Q4 results and analyst attention: Amprius reported results that beat expectations and flagged expanded analyst coverage, which helped validate the company’s growth story to the market. Earnings & Coverage
• Positive Sentiment: Record revenue and EBITDA inflection: Management highlighted record revenue growth and the company’s first quarter of positive adjusted EBITDA — a fundamental milestone that supports higher valuations and institutional interest. Revenue & EBITDA Story
• Positive Sentiment: Multiple price-target raises and reiterated buy ratings: Several firms updated coverage after the quarter — B. Riley raised its target (to $22), Needham reaffirmed a Buy with a $20 target, Roth/MKM and others reiterated Buy views — providing buy-side momentum and cover for investors. (See firm notes cited in recent coverage.)
• Positive Sentiment: Technical/volume breakout supports continuation: MarketBeat and others point to sharply higher trading volume and technical convergence (daily/weekly/monthly) that often precedes sustained moves — increased liquidity and volume validate the rally and can attract momentum traders. Volume & Technical Signal
• Neutral Sentiment: Analyst forecasts shifting positive but mixed timing: Firms like Northland have raised multi-quarter and FY2027 EPS estimates (turning to positive EPS in 2027), which supports a longer-term rerating but leaves the near-term consensus for the current year still negative. (Research note summaries circulated 3/9–3/10.)
• Negative Sentiment: Profitability, valuation and concentration risks remain: Despite milestones, Amprius is still generating negative net margins and the consensus for the current fiscal year remains a loss (-$0.45 EPS). The stock is high-beta and volatile, institutional ownership is still modest, and upside depends on continued execution and contract wins (e.g., NDAA compliance progress and defence/customer ramps).

Hedge Funds Weigh In On Amprius Technologies

Several institutional investors have recently bought and sold shares of AMPX. Bank of America Corp DE increased its holdings in shares of Amprius Technologies by 31.1% in the 4th quarter. Bank of America Corp DE now owns 12,890 shares of the company’s stock worth $36,000 after buying an additional 3,055 shares during the last quarter. AQR Capital Management LLC lifted its holdings in shares of Amprius Technologies by 86.7% in the 1st quarter. AQR Capital Management LLC now owns 77,764 shares of the company’s stock valued at $208,000 after acquiring an additional 36,116 shares during the last quarter. Millennium Management LLC grew its position in Amprius Technologies by 94.5% in the first quarter. Millennium Management LLC now owns 1,396,013 shares of the company’s stock worth $3,741,000 after acquiring an additional 678,442 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in Amprius Technologies by 128.6% during the first quarter. Goldman Sachs Group Inc. now owns 244,646 shares of the company’s stock worth $656,000 after acquiring an additional 137,640 shares during the last quarter. Finally, Rhumbline Advisers increased its stake in Amprius Technologies by 61.1% during the first quarter. Rhumbline Advisers now owns 15,690 shares of the company’s stock worth $42,000 after acquiring an additional 5,951 shares during the last quarter. Institutional investors own 5.04% of the company’s stock.

Amprius Technologies Price Performance

The business has a 50-day simple moving average of $11.07 and a 200-day simple moving average of $10.82. The firm has a market capitalization of $2.34 billion, a PE ratio of -52.66 and a beta of 3.04.

Amprius Technologies (NYSE:AMPX) last announced its earnings results on Wednesday, March 4th. The company reported ($0.01) EPS for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.03. The firm had revenue of $25.23 million during the quarter, compared to analysts’ expectations of $22.91 million. Amprius Technologies had a negative return on equity of 25.77% and a negative net margin of 60.30%.Amprius Technologies has set its FY 2026 guidance at –0.060 EPS. On average, research analysts expect that Amprius Technologies, Inc. will post -0.45 earnings per share for the current year.

About Amprius Technologies

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.